Search
for
Sort by
Research 301–330 of 1000+
- Generalised Gingival Fibromatosis and Hypertrichosis: A Rare Case of Syndromic Presentation
- Multiple Benign Epidermal Inclusion Cysts Clinically Misdiagnosed as Rhinophyma: A Case Report
- Development and Characterization of Film Forming Spray of 5% Minoxidil for Baldness Due to Androgenetic Alopecia
- Contents
- Inefficiency of ethanolic extract of Glycyrrhiza glabra and Ziziphus mauritiana roots on androgenic alopecia
- The human keratins: biology and pathology
- Control of hair growth and follicle size by VEGF-mediated angiogenesis
- The Dynamics of the Skin’s Immune System
- Mucocutaneous reactions to chemotherapy
- Severe cutaneous adverse reactions to drugs
- The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults
- Herbal Therapy in Dermatology
- Cutaneous signs in COVID ‐19 patients: A review
- Histopathology of alopecia: a clinicopathological approach to diagnosis
- The pharmacology of methotrexate
- The Pathogenesis of Primary Cicatricial Alopecias
- Clinical manifestations of cutaneous lupus erythematosus
- Lupus erythematosus: systemic and cutaneous manifestations
- Dermatological adverse events with taxane chemotherapy
- Vitamin D and the skin: Focus on a complex relationship: A review
- The Role of Vitamins and Minerals in Hair Loss: A Review
- Hypersensitivity reactions to anticoagulant drugs: diagnosis and management options
- Keratin disorders: from gene to therapy
- Oral retinoids-present status
- Long-term complications of Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN): the spectrum of chronic problems in patients who survive an episode of SJS/TEN necessitates multidisciplinary follow-up
- Cutaneous and Ocular Late Complications of Sulfur Mustard in Iranian Veterans
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
- Alopecia Areata Update
- Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms